W1789 The New Reflux Inhibitor Azd3355 Has a Low Propensity for Inducing Central Side Effects Due to Its Affinity for the GABA Carrier
Anders Lehmann(AstraZeneca (United Kingdom)), Sverker von Unge, Pirjo Saransaari, Jan P. Mattsson(Novartis (Switzerland)), Karolina Nilsson, Thomas Elebring(AstraZeneca (Sweden)), L. Ashley Blackshaw
Cited by 4
Related Papers
Ischemia-Induced Shift of Inhibitory and Excitatory Amino Acids from Intra- to Extracellular Compartments
|Journal of Cerebral Blood Flow & Metabolism|1985|660
Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain
|Microbiome|2022|352
Control of transient lower esophageal sphincter relaxations and reflux by the GABAB agonist baclofen in normal subjects
|Gastroenterology|2000|326
Effects of <i>In Vivo</i> Administration of Kainic Acid on the Extracellular Amino Acid Pool in the Rabbit Hippocampus
|Journal of Neurochemistry|1983|214